Safety and immunogenicity of inactivated poliovirus vaccine when given with measles–rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia

Ed Clarke*, Yauba Saidu, Jane U. Adetifa, Ikechukwu Adigweme, Mariama Badjie Hydara, Adedapo O. Bashorun, Ngozi Moneke-Anyanwoke, Ama Umesi, Elishia Roberts, Pa Modou Cham, Michael E. Okoye, Kevin E. Brown, Matthias Niedrig, Panchali Roy Chowdhury, Ralf Clemens, Ananda S. Bandyopadhyay, Jenny Mueller, David J. Jeffries, Beate Kampmann

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of inactivated poliovirus vaccine when given with measles–rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia'. Together they form a unique fingerprint.

Medicine & Life Sciences